-+ 0.00%
-+ 0.00%
-+ 0.00%

Is Genpact (G) Undervalued After Its Agentic AI Launch And Product Leadership Hire?

Simply Wall St·09/02/2026 11:21:40
Listen to the news

Genpact (G) stock is in focus after the company launched its Genpact Record-to-Report Suite, an agentic AI platform for finance teams, and appointed Priya Vijayarajendran as Chief Product and Platform Officer.

Against this backdrop, Genpact's recent agentic AI push comes after a sharp reset in the stock earlier in the year, with the year to date share price return down 17.9%, even as momentum has picked up with a 30 day share price return of 7.2% and a 90 day share price return of 16.7%. Over a longer horizon, total shareholder return is mixed, with a decline of 14.5% over one year but a positive 6.3% over three years and a 20.9% decline over five years. This may signal that recent product launches and leadership changes are being viewed as a potential shift in growth profile or risk perception rather than a complete reversal of the longer term trend.

Scan how Genpact's AI pivot compares with other companies pushing hard into automation and data-led efficiency by reviewing the hand-picked 75 profitable AI stocks that aren't just burning cash.

Genpact now trades at a sizable discount to one set of fair value markers, even after the recent rebound. Is that a reasonable cushion for execution risk on the agentic AI shift, or is it a sign the market still sees unfinished work on the story ahead?

Most Popular Narrative: 10.6% Undervalued

The most followed Genpact narrative pegs fair value at $42.18 per share, compared with the last close at $37.69. That implies a valuation gap investors will want to understand before forming a view on the stock.

Genpact's strong pipeline, particularly in high-growth verticals like high tech, manufacturing, and financial services, combined with increasing large-deal activity and stable operating leverage, is described as supporting revenue and EPS growth above the sector average, along with operating margin expansion and continued return of capital to shareholders.

Read the complete narrative.

Analysts are not just plugging in generic growth. The narrative leans on a specific mix of revenue expansion, margin shifts and future earnings multiples that together support that fair value. Curious which assumptions matter most to Genpact and how they stack up against the current share price gap?

Result: Fair Value of $42.18 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, the Genpact narrative still hinges on Advanced Technology Solutions offsetting slower legacy operations and on large, multi year contracts converting as expected.

Find out about the key risks to this Genpact narrative.

Next Steps

If the mixed sentiment around Genpact leaves you unsure, take a closer look at the data yourself and consider both sides through the 5 key rewards and 1 important warning sign.

Looking for more investment ideas beyond Genpact?

If Genpact has your attention, do not stop there. Use the same structured approach across other opportunities so your portfolio reflects more than one compelling story.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.